Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.

2 September 2026 · By · Wire by Fusion42

Published

2 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Canada

◆ Source

Read at bnnbloomberg.ca →

◆ Verified

Fusion42 · 2 September 2026 · Fusion42 review

Kane Biotech has entered a non-exclusive distribution agreement with Ontario Medical Supply Inc. to market and support its FDA-cleared and Health Canada-approved revyve Antimicrobial Wound Gel products across Canada, leveraging OMS's access to the Ontario Health atHome formulary.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You gain a clearer route to scale wound care solutions in Canada with a partner inside the Ontario Health atHome network. The large volume of wound care visits there means this deal now directly opens a valuable sales channel.

◆ Coverage

1 source · 2 Sep 2026

◆ Related on Wire

◆ Topics

Medtechwound-caredistributionmedical-supplyhealthcare-accessCanada